$36.55 -0.50 (-1.35%)
2/10/2012 4:01 PM

Par Pharmaceutical Companies, Inc. (NYSE:PRX)

CAPS Rating: 3 out of 5

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

Featured Broker Partners


Advertisement